JP2022544068A5 - - Google Patents
Info
- Publication number
- JP2022544068A5 JP2022544068A5 JP2022506163A JP2022506163A JP2022544068A5 JP 2022544068 A5 JP2022544068 A5 JP 2022544068A5 JP 2022506163 A JP2022506163 A JP 2022506163A JP 2022506163 A JP2022506163 A JP 2022506163A JP 2022544068 A5 JP2022544068 A5 JP 2022544068A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- acid sequence
- seq
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962881547P | 2019-08-01 | 2019-08-01 | |
| US62/881,547 | 2019-08-01 | ||
| PCT/US2020/044515 WO2021022166A1 (en) | 2019-08-01 | 2020-07-31 | Antibody specific for gpc3 and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544068A JP2022544068A (ja) | 2022-10-17 |
| JP2022544068A5 true JP2022544068A5 (https=) | 2023-08-03 |
| JP7828272B2 JP7828272B2 (ja) | 2026-03-11 |
Family
ID=74228511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506163A Active JP7828272B2 (ja) | 2019-08-01 | 2020-07-31 | Ｇｐｃ３特異的抗体およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12595314B2 (https=) |
| EP (1) | EP4007604A4 (https=) |
| JP (1) | JP7828272B2 (https=) |
| KR (1) | KR20220083665A (https=) |
| CN (1) | CN114340671A (https=) |
| AU (1) | AU2020319874A1 (https=) |
| CA (1) | CA3148807A1 (https=) |
| WO (1) | WO2021022166A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118488970A (zh) * | 2021-10-15 | 2024-08-13 | 乐普创一生物科技（上海）有限公司 | 抗磷脂酰肌醇蛋白聚糖3抗体 |
| WO2025023650A1 (ko) * | 2023-07-21 | 2025-01-30 | 한국생명공학연구원 | 신규한 항-gpc3 키메릭 항원 수용체 및 이를 발현하는 면역세포 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004022597A1 (ja) | 2002-09-04 | 2004-03-18 | Chugai Seiyaku Kabushiki Kaisha | Gpc3の血中可溶化ｎ端ﾍﾟﾌﾟﾁﾄﾞに対する抗体 |
| AU2002330482A1 (en) | 2002-09-04 | 2004-03-29 | Perseus Proteomics Inc. | Method of diagnosing cancer by detecting gpc3 |
| SI1674111T1 (sl) * | 2004-07-09 | 2011-02-28 | Chugai Pharmaceutical Co Ltd | Protitelo proti glipikanu 3 |
| US20070087005A1 (en) | 2005-10-14 | 2007-04-19 | Lazar Gregory A | Anti-glypican-3 antibody |
| WO2007137170A2 (en) * | 2006-05-20 | 2007-11-29 | Seattle Genetics, Inc. | Anti-glypican-3 antibody drug conjugates |
| US7985783B2 (en) | 2006-09-21 | 2011-07-26 | The Regents Of The University Of California | Aldehyde tags, uses thereof in site-specific protein modification |
| WO2009120611A2 (en) | 2008-03-27 | 2009-10-01 | The Regents Of The University Of California | Aldehyde tags, uses thereof in site-specific protein modification |
| WO2010096394A2 (en) | 2009-02-17 | 2010-08-26 | Redwood Biosciences, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
| EP2699603B1 (en) * | 2011-04-19 | 2016-03-02 | The United States of America As Represented by the Secretary Department of Health and Human Services | Human monoclonal antibodies specific for glypican-3 and use thereof |
| EP3539563A1 (en) | 2012-07-19 | 2019-09-18 | Redwood Bioscience, Inc. | Antibody specific for cd22 and methods of use thereof |
| WO2015179658A2 (en) * | 2014-05-22 | 2015-11-26 | Genentech, Inc. | Anti-gpc3 antibodies and immunoconjugates |
| KR101796688B1 (ko) | 2015-10-29 | 2017-12-01 | 재단법인 목암생명과학연구소 | 신규 항-글리피칸 3 항체 및 이를 포함하는 약학적 조성물 |
| US20170326249A1 (en) * | 2016-05-10 | 2017-11-16 | Bristol-Myers Squibb Company | Antibody-drug conjugate of an anti-glypican-3 antibody and a tubulysin analog, preparation and uses |
-
2020
- 2020-07-31 KR KR1020227006314A patent/KR20220083665A/ko active Pending
- 2020-07-31 AU AU2020319874A patent/AU2020319874A1/en active Pending
- 2020-07-31 CA CA3148807A patent/CA3148807A1/en active Pending
- 2020-07-31 EP EP20845986.7A patent/EP4007604A4/en active Pending
- 2020-07-31 US US17/629,297 patent/US12595314B2/en active Active
- 2020-07-31 WO PCT/US2020/044515 patent/WO2021022166A1/en not_active Ceased
- 2020-07-31 CN CN202080062015.4A patent/CN114340671A/zh active Pending
- 2020-07-31 JP JP2022506163A patent/JP7828272B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6947639B2 (ja) | 二重特異性四価抗体並びにその製作及び使用方法 | |
| EP2788379B1 (en) | Pdgf receptor beta binding polypeptides | |
| KR102838340B1 (ko) | 다중-특이적 항체 및 이들의 제조 및 사용 방법 | |
| EA036236B1 (ru) | БИСПЕЦИФИЧЕСКИЕ МОНОВАЛЕНТНЫЕ ДИАТЕЛА, КОТОРЫЕ СПОСОБНЫ СВЯЗЫВАТЬСЯ С gpA33 И CD3, И ИХ ПРИМЕНЕНИЯ | |
| JP2006511516A5 (https=) | ||
| US11814441B2 (en) | Bi-specific antigen-binding polypeptides | |
| CN110914297A (zh) | 抗人白细胞介素2抗体及其用途 | |
| CN116829186A (zh) | 多特异性抗体及其用途 | |
| CN115916816A (zh) | 抗血清白蛋白抗体 | |
| JP2026505129A (ja) | 抗ｃｄｈ１７抗体及びその使用 | |
| CN115279412A (zh) | 偶联脂肪酸分子的抗体及其用途 | |
| JP2022544068A5 (https=) | ||
| KR20230141839A (ko) | 전하쌍을 갖는 이중 특이성 항체 및 이의 용도 | |
| JP2026506070A (ja) | 抗ｃｎｔｎ４抗体及びその使用 | |
| CN119677777A (zh) | 抗cd28抗体 | |
| JP2023548471A5 (https=) | ||
| JP2023536630A5 (https=) | ||
| US20230242640A1 (en) | ANTI-SIRPg Compounds | |
| JP2022551844A5 (https=) | ||
| Li et al. | Antibodies and their multivalent constructs for cancer therapy | |
| WO2023273958A1 (zh) | 三特异性抗体、其制备方法和用途 | |
| HK40088389A (zh) | 针对folr1的双特异性抗体及其用途 | |
| HK40088389B (zh) | 针对folr1的双特异性抗体及其用途 | |
| TW202537642A (zh) | 抗體藥物綴合物 | |
| HK40128164A (zh) | Triax抗体的组合物及其制备和使用方法 |